The collaboration aims to broaden access of premium medical cannabis products to Australian patients EDMONTON, AB, Dec. 17, 2024 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce a distribution partnership between The Entourage Effect and MedReleaf Australia. The Entourage Effect provides comprehensive distribution and... Read more
TORONTO, Dec. 17, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") and Kensana Health Inc. ("Kensana Health") are pleased to announce that they have entered into a share purchase agreement (the "Purchase Agreement") for the purchase and sale of MediPharm's facility in Napanee, Ontario (the "Napanee Facility") through a disposition of all of the Company's... Read more
According to the LOI, SciSparc’s pharmaceuticals assets are valued at approximately US$11.6 million TEL AVIV, Israel, Dec. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it had signed an... Read more
New Muscogee County location will host grand opening celebration Friday, December 20th TALLAHASSEE, Fla., Dec. 13, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical cannabis dispensary in Columbus, Georgia. A grand opening celebration... Read more
Promising Findings Presented at the American College of Neuropsychopharmacology Annual Meeting LOUISVILLE, Colo., Dec. 12, 2024 /CNW/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") the market leader in cannabidiol (CBD) hemp extract wellness products, is pleased to share an update on the progress of DeFloria LLC's ("DeFloria") botanical pharmaceutical... Read more
New Hillsborough County location will host grand opening celebration Friday December 13 TALLAHASSEE, Fla., Dec. 9, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida. A grand opening celebration will be held... Read more
Vancouver, British Columbia--(Newsfile Corp. - December 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly owned subsidiary BioGene Therapeutics Inc. has appointed Patroski... Read more
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly owned subsidiary BioGene Therapeutics Inc. has appointed Dr.... Read more
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce the initial delivery of its proprietary topical products into Europe as a part of the previously announced exclusive supply... Read more
PharmaCielo achieved 85% Year-Over-Year Sales Growth, Generating Year-to-Date Q3 Total Revenue of $2.4 Million Q3 Gross Profit Turned Positive Reflecting More Diverse Customer Base Q3 Cash Flow Improved and EBITDA Increased by $0.8 Million Reflecting Strong Sales Growth and Reduced Costs Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - December 2, 2024) - PharmaCielo Ltd. (TSXV: PCLO)... Read more
Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly owned subsidiary BioGene Therapeutics Inc. has appointed as an... Read more
The Company achieved a total revenue of $13.6 million. Gross Profit Margins continue to demonstrate a solid performance with 30% growth year-over-year. SG&A achieves a significant reduction, reflecting the Company's notable 32% decrease year-over-year. EBITDA improves by 70% for the quarter and 65% year-over-year, reflecting progress toward profitability. Management will host a conference call on November... Read more
Q3 Revenue improves 3.5% Year-over-Year to $26.1 million Delivers $7.5 million in Adjusted EBITDA, representing 29% margin Generates $9.6 million in Positive Cash Flow from Operations TAMPA, fLA., Nov. 29, 2024 /CNW/ - Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today... Read more
HERZLIYA, Israel and CALGARY, AB, Nov. 26, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to report positive results from a basic safety assessment study, evaluating LPT-CBD administered as a single injection in Göttingen minipigs. The drug was administered in three ascending... Read more
Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB, Nov. 26, 2024 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces developments in cannabis science from Aurora's world class research and genetics facility, Aurora Coast. With a continued focus on premium, science-driven insights, these... Read more
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly owned subsidiary BioGene Therapeutics Inc. has appointed Dr.... Read more
New Duval County location will host grand opening celebration Friday, December 6th TALLAHASSEE, Fla., Nov. 22, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Jacksonville, Florida on Saturday, November 23. A grand opening celebration... Read more
TAMPA, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically integrated, multi-state cannabis company operating under the FLUENT™ brand, is proud to announce the launch of Hyer Kind, a cosmic voyage into the world of premium cannabis concentrates. Now exclusively available at all FLUENT dispensaries across Florida, Hyer Kind brings... Read more
SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has entered into a definitive agreement (the "Purchase Agreement") to acquire Extract Labs, Inc. ("Extract Labs"), a leading... Read more
Fort Lauderdale, Florida--(Newsfile Corp. - November 20, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is positioning itself as a first mover in response to Australia's recent regulatory changes by offering a comprehensive range of products tailored to meet the evolving needs of pharmacies. With the Australian Government's new regulations shifting the supply of disposable nicotine... Read more
2.7X Revenue Growth Year-Over-Year at US $24 Million for 9-month Period HERZLIYA, Israel and CALGARY, Alberta, Nov. 20, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce its consolidated financial results for the three... Read more
Grand opening celebrations at both new locations Friday, November 22nd TALLAHASSEE, Fla., Nov. 19, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of new medical cannabis dispensaries in Dania Beach and Spring Hill, Florida. Grand opening celebrations will be held at... Read more
NEUMÜNSTER, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced the launch of its first commercial German grown medical cannabis... Read more
SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2024. Third Quarter 2024 and Recent Financial and Operating... Read more
Strong Growth in International GMP Medical Markets TORONTO, Nov. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three and nine months ended September 30, 2024. Key Highlights Adjusted EBITDA(1): Negative $743K... Read more
Strong Growth in International GMP Medical Markets TORONTO, Nov. 14, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three and nine months ended September 30, 2024. Key Highlights Adjusted EBITDA(1): Negative $743K in the... Read more
MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announced that Amethyst Health, LLC (“Amethyst Health”), has been conditionally awarded a vertically integrated medical cannabis “Registered Organization” license by New York State, at today’s meeting of the New York Cannabis Control... Read more
A recent National Pet Owners Survey demonstrates a significant addressable market for Innocan's veterinary product HERZLIYA, Israel and CALGARY, AB, Nov. 11, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, announced that it has taken the strategic decision to focus its development... Read more
SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the final results of a new scientific study their team has supported... Read more
Delivered Q3 2024 revenue of $8.4 million Reported net loss of $1.1 million and adjusted EBITDA 1 of $0.4 million SEATTLE / Nov 07, 2024 / Business Wire / Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its third quarter ended September 30, 2024. "With two consecutive... Read more
Fort Lauderdale, Florida--(Newsfile Corp. - November 4, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today reaffirms its medical cannabis supply agreement with Curaleaf Holdings, Inc. subsidiary Northern Green Canada, Inc. This morning, Curaleaf also confirmed on X (Formerly known as Twitter) that “Curaleaf has entered into an agreement to supply cannabis products to Flora Growth... Read more
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that it has signed a definitive agreement on the 29 October, 2024 (the... Read more
New Highlands County location will host grand opening celebration Friday, November 1st TALLAHASSEE, Fla., Oct. 25, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Lake Placid, Florida. A grand opening celebration will be held... Read more
New location in South Florida marks the Company's 66th dispensary in the state STAMFORD, Conn., Oct. 23, 2024 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced it has opened a new medical dispensary in Miami, Florida. Curaleaf Miami Bird Road, located at 8868 SW Bird Rd., Miami, FL 33165,... Read more
Management Guides Fourth Quarter Revenues to Grow to at Least $7.2 Million USD; Reaffirms Goal to Complete Nasdaq Uplisting by Year-End Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today preannounced... Read more
New Orange County location will host grand opening celebration Friday, October 25th TALLAHASSEE, Fla., Oct. 18, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Orlando, Florida. A grand opening celebration will be held Friday,... Read more
Grand opening celebrations scheduled for Friday, October 18th TALLAHASSEE, Fla., Oct. 15, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of new Florida medical cannabis dispensaries in Bonita Springs and St. Augustine. Grand opening celebrations at both... Read more
HERZLIYA, Israel and CALGARY, Alberta, Oct. 11, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce promising results from a multi-year compassionate therapy using repeated liposomal-CBD (LPT-CBD) injections for pain relief in dogs with naturally-occurring... Read more
New Broward County location will host grand opening celebration Friday, October 11th TALLAHASSEE, Fla., Oct. 7, 2024 /CNW/ --Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Hallandale Beach, Florida. A grand opening celebration will be held... Read more
FDA confirms that SciSparc’s study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that the U.S. Food and Drug Administration... Read more
COPYRIGHT ©2022 GREEN STOCK NEWS